跳轉至內容
Merck
全部照片(1)

文件

75061

Sigma-Aldrich

三叔丁基1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸

≥95.0% (CHN)

同義詞:

1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸三叔丁酯

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C28H52N4O8
CAS號碼:
分子量::
572.73
MDL號碼:
分類程式碼代碼:
12352108
PubChem物質ID:
NACRES:
NA.22

品質等級

化驗

≥95.0% (CHN)

形狀

lumps

SMILES 字串

CC(C)(C)OC(=O)CN1CCN(CCN(CCN(CC1)CC(=O)OC(C)(C)C)CC(=O)OC(C)(C)C)CC(O)=O

InChI

1S/C28H52N4O8/c1-26(2,3)38-23(35)19-30-12-10-29(18-22(33)34)11-13-31(20-24(36)39-27(4,5)6)15-17-32(16-14-30)21-25(37)40-28(7,8)9/h10-21H2,1-9H3,(H,33,34)

InChI 密鑰

RVUXZXMKYMSWOM-UHFFFAOYSA-N

相關類別

應用

1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸三丁酯(tri BOC-DOTA)可作为反应物来制备:
  • 以DOTA-LAE(乳糖酸-乙二胺)功能化修饰的钆离子,其可用作磁共振成像(MRI)的造影剂。
  • 熊果酸的DOTA偶联物和ZD264Cu-DOTA偶联物

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

dust mask type N95 (US), Eyeshields, Gloves


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Benjamin Poret et al.
Biomolecules, 10(3) (2020-03-25)
Overexpression of G protein-coupled receptors (GPCRs) in tumours is widely used to develop GPCR-targeting radioligands for solid tumour imaging in the context of diagnosis and even treatment. The human vasoactive neuropeptide urotensin II (hUII), which shares structural analogies with somatostatin
Synthesis of a gadolinium based-macrocyclic MRI contrast agent for effective cancer diagnosis
Jeong Y and Na K
Biomaterials research, 22(1), 17-17 (2018)
Preparation and evaluation of ZD2 peptide 64Cu-DOTA conjugate as a positron emission tomography probe for detection and characterization of prostate cancer
Han Z, et al.
ACS Omega, 4(1), 1185-1190 (2019)
Synthesis and cytotoxicity evaluation of DOTA-conjugates of ursolic acid
Kahnt, M, et al.
Molecules (Basel), 24(12), 2254-2254 (2019)
Lubinda Mbundi et al.
Nanomaterials (Basel, Switzerland), 8(6) (2018-06-06)
The control of osteoblast/osteoclast cross-talk is crucial in the bone remodelling process and provides a target mechanism in the development of drugs for bone metabolic diseases. Osteoprotegerin is a key molecule in this biosignalling pathway as it inhibits osteoclastogenesis and

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務